What is equity crowdfunding?
Equity crowdfunding refers to the online offering of private company securities to a large group of people who can participate with a relatively small investment. It has become especially popular since President Barack Obama signed the Jumpstart Our Business Startups (JOBS) Act into law in 2012.
Regulation A+ is a part of the JOBS Act, a law that allows companies to raise up to $50 million by offering stock participation to the general public. By opening itself up for an equity crowdfunding raise of this kind, BIOLIFE4D is enabling ALL people to own a piece of a potentially remarkable new process that could save millions of lives, and to share financially in its potential success. Yes, YOU can invest in and own a piece of BIOLIFE4D.
Investing in Mankind
Equity crowdfunding aligns perfectly with the company’s strategy and philosophy. BIOLIFE4D will strive to make this an affordable solution for the global population. An investment in BIOLIFE4D is not a donation, but rather an investment in the company’s goal of bettering humanity’s future.
Heart disease is the cause of one in every four deaths. In the U.S. alone, heart disease claims more than 610,000 lives every year. And yet, only around 5,000 cardiac transplants occur worldwide every year.
Heart disease doesn’t discriminate. It is the leading cause of death for both men and women. In fact, cardiovascular diseases surpass the annual mortality rate of all types of cancer combined. In the U.S. alone, one person dies of heart disease-related event every minute. And in China, cardiovascular disease claims a life every 10 seconds. This is a truly global problem.
As BIOLIFE4D succeeds, so too should its investors. With a projected market in the billions of dollars, bioprinting can be medicine’s next big frontier.
Ultimately, by providing viable tissues and/or organs bioprinted from a patient’s own cells to replace damaged or diseased organs, BIOLIFE4D plans to tap into a global market serving the continually expanding global human population. BIOLIFE4D’s innovative process will not be just for “the wealthiest one percent.”
Optimizing a proposed groundbreaking cardiac tissue regeneration and organ replacement process, BIOLIFE4D plans to address a critical unmet need in the treatment of this devastating disease. While BIOLIFE4D plans to focus on the human heart, the process may also be leveraged to address numerous other medical challenges.
Investing is Easy
Soon, you will be able to invest in BIOLIFE4D. Click here to indicate your interest and we will notify you when our stock is available for purchase. Once it is, you will be guided through the easy process to invest.